Sun Pharmaceutical Industries recalls Venlafaxine Hydrochloride after failing a dissolution test

MUMBAI: Sun Pharmaceutical Industries, India’s largest drug maker by sales, on Friday recalled about 40,000 bottles of anti-depressant Venlafaxine Hydrochloride for failing a dissolution test, the US Food and Drug Administration said.

The recall was made by Sun Pharma’s US subsidiary Caraco Pharmaceutical Laboratories for drugs manufactured in the company’s Indian facility.

"Stability results found the product did not meet the drug release dissolution specifications," the FDA said. Sun Pharma is the third Indian company to recall drugs in a month after Wockhardt and Dr Reddy’s Laboratories.